SCHEMBL25069731

SCHEMBL25069731

CCn1cc(C(=O)O)c(=O)c2c(N)c(F)c(NC3CCC3)cc21

nearest known ligand 0.94

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOXO1 Q12778 1/20 0.94
MEN1 O00255 6/20 0.54
KMT2A Q03164 6/20 0.54
GAA P10253 1/20 0.54
GSK3B P49841 4/20 0.49
HSD17B10 Q99714 5/20 0.41
HPGD P15428 6/20 0.40
KDM4E B2RXH2 5/20 0.40
ALDH1A1 P00352 5/20 0.40
TSHR P16473 3/20 0.40
RAB9A P51151 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
APEX1 P27695 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
DRD3 P35462 1/20 0.40
LMNA P02545 3/20 0.40
POLB P06746 2/20 0.40
TAAR1 Q96RJ0 1/20 0.40
HTT P42858 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25069274 0.98 FOXO1 (0.98) FOXO1MEN1KMT2AGAAGSK3B
SCHEMBL29431929 0.97 FOXO1 (1.00) FOXO1MEN1KMT2AGAAGSK3B
SCHEMBL17387387 0.97 FOXO1 (1.00) FOXO1MEN1KMT2AGAAGSK3B
SCHEMBL25069737 0.96 FOXO1 (0.90) FOXO1MEN1KMT2AGAAGSK3B
SCHEMBL25069367 0.92 FOXO1 (0.84) FOXO1MEN1KMT2AGAAGSK3B
SCHEMBL25069510 0.91 FOXO1 (0.82) FOXO1MEN1KMT2AGAAGSK3B
SCHEMBL24063597 0.90 FOXO1 (0.87) FOXO1MEN1KMT2AGAAGSK3B
SCHEMBL22341217 0.89 FOXO1 (0.79) FOXO1MEN1KMT2AGAAGSK3B
SCHEMBL22280135 0.88 FOXO1 (0.84) FOXO1MEN1KMT2AGAAGSK3B
SCHEMBL1242709 0.88 FOXO1 (0.83) FOXO1MEN1KMT2AGAAGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230058189-A1 QUINOLIN-4-ONE AND 4(1H)-CINNOLINONE COMPOUNDS AND METHODS OF USING SAME Frequency Therapeutics, Inc. (US) 2023-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230058189-A1 QUINOLIN-4-ONE AND 4(1H)-CINNOLINONE COMPOUNDS AND METHODS OF USING SAME DCX, NES, MCL1 FOXO1 224/4885MEN1 654/4885KMT2A 3542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.